Researchers developed an AI tool that analyzes genetic data to identify risk factors for stroke, which can lead to personalized risk assessments and targeted prevention strategies. The tool was more accurate than previous genetic risk tools in distinguishing people who had suffered a stroke from those who had not.
Researchers have created a new tool, EN-TEx, to analyze genetic mutations and predict disease risk. The catalog of allele-specific variants provides rich data for accurate personal genomics, enabling scientists to study the effects of genetic mutations in tissues that are difficult to obtain without surgery.
Researchers at Johns Hopkins Kimmel Cancer Center discovered differences in gene activity between immune cells from patients with lung cancer who responded and did not respond to immunotherapies. The findings suggest that non-responders' immune cells can be reprogrammed to act more like responders', potentially leading to new treatment...
A Canadian Medical Association Journal study has found genetic variants associated with diseases and adverse drug reactions in 56 healthy participants. The results suggest that whole genome sequencing can benefit Canada's health care, but also highlight potential pitfalls and the need for careful evaluation.
Researchers found that when participants understand the implications of data sharing, they are willing to consent. The study's findings could inform revisions to the Common Rule, requiring researchers to obtain consent from patients for using their biological samples and personal data through public online databases.
23andMe is opening its API to third-party developers, enabling them to create new web-based interactive tools using the company's DNA data. Approved developers will receive an authentication key to access the platform.
VAAST, a new probabilistic disease-gene finder, rapidly searches personal genomes for genes with disease-causing mutations. The tool improves upon existing methods with regard to statistical power, flexibility, and scope of use.
Advances in DNA sequencing technology make it possible for consumers to access their 'personal genome' for disease prevention and treatment strategies. The cost of sequencing is expected to drop sharply, raising ethical and legal concerns about genetic information use.